공시 • Jun 05
Glucose Health, Inc. Announces Appointment of Gerry David as Chairman of Strategic Advisory Board Glucose Health, Inc. announced the appointment of Gerry David as Chairman of its newly formed Strategic Advisory Board of Directors. In this role, Mr. David will work closely with the Company’s leadership team to help develop and execute a coordinated business development strategy aimed at expanding Glucose Health’s presence in the dietary fiber and functional beverage markets. Gerry David brought over 40 years of experience in driving successful corporate turnarounds. His most notable achievement came as CEO of NASDAQ-listed Celsius Holdings, Inc. (CELH), where he transformed a struggling beverage brand on the brink of failure into a thriving, global company. Under his leadership, Celsius (CELH) achieved five consecutive years of record revenues and increased shareholder value by 35 times. He spearheaded the company’s international expansion, establishing a subsidiary in Hong Kong, launching products across Asia, South America, Europe, and the Middle East, and setting up manufacturing facilities in Germany, China, and the United States. In recognition of his remarkable leadership, he was named one of only 25 Gold Winners in the prestigious CEO World Awards and honored as “The Leader” in the CEO of the Year category in 2016. 공시 • Feb 05
Glucose Health, Inc. announced that it has received $0.1 million in funding On February 4, 2026, Glucose Health, Inc. closed the transaction. 공시 • Dec 06
Glucose Health, Inc. announced that it has received $0.02 million in funding On December 5, 2025, Glucose Health, Inc. closed the transaction. The transaction included participation from two investors. 공시 • Oct 29
Glucose Health, Inc. Appoints Christopher J. Jemapete to Its Board of Directors, Effective October 29, 2025 Glucose Health, Inc. announced a further strengthening of its Board of Directors with the appointment of Christopher J. Jemapete, effective October 29, 2025. Mr. Jemapete was an early strategic investor in Glucose Health, Inc. beginning in 2017 and continues to maintain a substantial equity position in the company. Mr. Jemapete brings three decades of experience in the financial services and securities industry to the Board of Directors of Glucose Health, Inc., having held senior roles with prominent Wall Street firms, including E.F. Hutton, Shearson Lehman Brothers, and Fidelity Investments. Mr. Jemapete concluded his professional career with a tenure at ALPS Distributors, Inc., located in Denver, Colorado, before his retirement in 2010. Since retiring, Mr. Jemapete has dedicated his efforts to identifying and supporting investment opportunities in the micro-cap sector of the equity markets. Through his deep research methodology, he has developed a comprehensive understanding of the operational and financial challenges faced by emerging companies—particularly in areas related to capital formation, financing structures, and the execution of strategic growth initiatives. As one of the earliest strategic investors in Glucose Health, Inc. Mr. Jemapete has participated in each of the Private Placements offered by Glucose Health, Inc. since 2019 and played an essential role in the successful raising of over $2 million in capital. His firm conviction in the mission of Glucose Health, Inc. —to deliver functional food and beverage products designed to address the growing public health challenges of obesity and diabetes—led to his decision today, to join the Company’s Board of Directors. Mr. Jemapete holds a Bachelor of Science degree in Marketing from Fairfield University in Fairfield, Connecticut, and completed a two-year graduate program at Adelphi University in Garden City, New York, earning certification as a Certified Financial Planner. 공시 • Oct 23
Glucose Health, Inc. Appoints Edmund “Ned” Burke to Its Board of Directors Glucose Health, Inc. announced the appointment of Edmund (Ned) Burke, a highly accomplished financial services executive, to its Board of Directors. With more than four decades of leadership experience at prominent investment firms including Pioneer Funds and Fidelity Investments, Mr. Burke brings exceptional financial acumen and strategic insight to the company’s leadership team. Mr. Burke most recently served as Chief Executive Officer of ALPS Distributors, Inc., where he played a pivotal role in the successful distribution of closed-end funds and exchange-traded funds (ETFs). Under his direction, ALPS expanded its services to include critical back-office accounting and transfer services for many of the nation’s top money management firms. During his tenure, Mr. Burke established and managed key relationships with notable organizations such as Select Sector SPDR Exchange Traded Funds, GE Investment Management, and Clough closed-end funds.His outstanding contributions to the financial services industry were recognized in 2016 when he received the NOVA Award from the National Investment Company Service Association, honoring his leadership and innovation in the securities sector. As CEO, Mr. Burke oversaw impressive growth at ALPS, expanding the firm’s Assets Under Management (AUM) from $15 million to $225 million, representing a compound annual growth rate of 19.79% over approximately 15 years. In 2005, he successfully negotiated the sale of ALPS to Lovell Minnick Partners, a private equity firm specializing in financial services investments. Later, in 2011, DST Systems, Inc. acquired ALPS after Mr. Burke had firmly established it as a leading player in the financial services industry. Mr. Burke’s extensive experience in building and scaling financial organizations will be invaluable as Glucose Health, Inc., continues to expand operations and enhance shareholder value. In addition to his new role at Glucose Health, Mr. Burke serves on the boards of several prominent money management firms, including Financial Investors Trust, Clough Funds, and Liberty All-Star Trust.Mr. Burke earned a Bachelor of Arts degree in Economics from the University of New Hampshire. 